Rosetta Working to Settle Dispute with US Marketing Partner Over Dx-Development Deal

Meanwhile, Rosetta continues to make progress with its diagnostic pipeline and expects to launch one new test before the end of this year and two others by the end of 2011. The company is also exploring opportunities outside of cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.